Literature DB >> 7060850

Blood flow in the diabetic neuropathic foot.

M E Edmonds, V C Roberts, P J Watkins.   

Abstract

The mechanisms which underlie the development of Charcot joints and foot ulceration are poorly understood. The present study using non-invasive Doppler techniques demonstrates that in the neuropathic leg, the arteries are rigid, peripheral blood flow is increased and associated with arteriovenous shunting. We studied 10 diabetics with severe neuropathy (including five with Charcot changes), 16 diabetics without neuropathy and 10 control subjects. Markedly abnormal blood velocity profiles (sonograms) were demonstrated only in those patients with severe neuropathy. They showed increased diastolic flow (indicated by a reduced Pulsatility Index of 2.88 +/- 0.8 (mean +/- SD) compared with 9.53 +/- 4.0 (p less than 0.001) in the diabetics without neuropathy and 10.8 +/- 3.7 (p less than 0.001) in the control subjects) suggesting arteriovenous shunting. Increased rigidity was indicated by decreased transit times -57 +/- 6.3 ms (mean +/- SD) in the diabetics with neuropathy compared with 66 +/- 7.6 ms (p less than 0.01) in the diabetics without neuropathy and 67 +/- 9.1 ms (p less than 0.05) in the control subjects. This was accompanied by raised ankle systolic pressures -199 +/- 22 mmHg (mean +/- SD) in the diabetics with neuropathy compared with 151 +/- 15 mmHg, (p less than 0.001) in the diabetics without neuropathy and 146 +/- 18 mmHg (p less than 0.001) in the control subjects. Medial wall calcification occurred almost exclusively in the neuropathic subjects. These alterations in blood flow which include arteriovenous shunting may be important in the pathogenesis of complications of the neuropathic leg.

Entities:  

Mesh:

Year:  1982        PMID: 7060850     DOI: 10.1007/bf00253862

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  [Pedal arteriovenous shunt in the treatment of trophic disorders of ulcero-mutilating acropathy].

Authors:  C Lefaucher; J Bardoux; B Fréneaux
Journal:  Nouv Presse Med       Date:  1975-10-04

Review 2.  NORMAL ARTERIOVENOUS ANASTOMOSES.

Authors:  J L SHERMAN
Journal:  Medicine (Baltimore)       Date:  1963-07       Impact factor: 1.889

3.  [Nonfamilial pseudosyringomyelic ulceromutilating acropathies of the lower limbs; concerning 23 observations].

Authors:  Y BUREAU; H BARRIERE; J P KERNEIS; A DE FERRON
Journal:  Presse Med       Date:  1957-12-25       Impact factor: 1.228

4.  The anatomy and histochemistry of the arteriovenous anastomosis in human digital skin.

Authors:  H J HURLEY; H MESCON; G MORETTI
Journal:  J Invest Dermatol       Date:  1956-09       Impact factor: 8.551

5.  Aetiology and management of lesions of the feet in diabetes.

Authors:  R C CATTERALL; M M MARTIN; W OAKLEY
Journal:  Br Med J       Date:  1956-10-27

6.  [Vascular regulation disorders in ulcerative and mutilating neuropathies of the lower extremities].

Authors:  H Partsch
Journal:  Vasa       Date:  1978       Impact factor: 1.961

7.  [Doppler-sonographic findings in media sclerosis of the extremities, verified by radiography].

Authors:  H Podhaisky; A Amthor; K Hänsgen; E G Preuss; R Sternitzky
Journal:  Z Gesamte Inn Med       Date:  1979-04-15

8.  Small and large vessel disease in the development of foot lesions in diabetics.

Authors:  I Fair
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

9.  Cardiac denervation in diabetes.

Authors:  T Wheeler; P J Watkins
Journal:  Br Med J       Date:  1973-12-08

10.  Early arterial lesions in maturity onset diabetes mellitus detected by an ultrasonic technique.

Authors:  S A Cairns; J P Woodcock; A J Marshall
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

View more
  46 in total

1.  Selective neuropathy and preserved vascular responses in the diabetic Charcot foot.

Authors:  M J Stevens; M E Edmonds; A V Foster; P J Watkins
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

2.  A comparison of peripheral vasoconstrictor responses and cardiovascular autonomic function tests in diabetic patients.

Authors:  J E Gilmore; J A Allen; J R Hayes
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

3.  Decreased muscle endurance associated with diabetic neuropathy may be attributed partially to neuromuscular transmission failure.

Authors:  Matti D Allen; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

4.  A new method of screening for diabetic neuropathy using laser Doppler and photoplethysmography.

Authors:  Sung Woo Kim; Soo Chan Kim; Ki Chang Nam; Eun Seok Kang; Jae Jung Im; Deok Won Kim
Journal:  Med Biol Eng Comput       Date:  2007-10-10       Impact factor: 2.602

Review 5.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

Review 6.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 7.  Diabetic neuropathies. Current concepts in prevention and treatment.

Authors:  J D Ward
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

8.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography.

Authors:  S Tesfaye; N Harris; J J Jakubowski; C Mody; R M Wilson; I G Rennie; J D Ward
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Successful treatment of osteomyelitis and soft tissue infections in ischemic diabetic legs by local antibiotic injections and the end-diastolic pneumatic compression boot.

Authors:  R S Dillon
Journal:  Ann Surg       Date:  1986-12       Impact factor: 12.969

10.  A three species model to simulate application of Hyperbaric Oxygen Therapy to chronic wounds.

Authors:  Jennifer A Flegg; Donald L S McElwain; Helen M Byrne; Ian W Turner
Journal:  PLoS Comput Biol       Date:  2009-07-31       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.